U.S. Senate · 117th Congress · S. 154
Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2021
A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Ted CruzR-TX
- Introduced
- February 2, 2021, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (3)
3 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Joni ErnstR-IA
- Ron JohnsonR-WI
Signed on later
- Mike LeeR-UTApril 20, 2021